Benchmark Co. Maintains ATI Physical Therapy(ATIP.US) With Hold Rating
ATI Physical Therapy (ATIP) Gets a Hold From Benchmark Co.
Analysts Offer Insights on Healthcare Companies: Fusion Pharmaceuticals (FUSN) and ATI Physical Therapy (ATIP)
Deutsche Bank Maintains Hold on ATI Physical Therapy, Lowers Price Target to $0.65
Benchmark Company Trims ATI Physical Therapy's Price Target to $2 From $4, Maintains Buy Rating
ATI Physical Therapy Is Maintained at Buy by Benchmark
ATI Physical Therapy Price Target Cut to $2.00/Share From $4.00 by Benchmark
Benchmark Maintains Buy on ATI Physical Therapy, Lowers Price Target to $2
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI) and ATI Physical Therapy (ATIP)
No Data
No Data